JP2022536341A5 - - Google Patents

Info

Publication number
JP2022536341A5
JP2022536341A5 JP2021573273A JP2021573273A JP2022536341A5 JP 2022536341 A5 JP2022536341 A5 JP 2022536341A5 JP 2021573273 A JP2021573273 A JP 2021573273A JP 2021573273 A JP2021573273 A JP 2021573273A JP 2022536341 A5 JP2022536341 A5 JP 2022536341A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
sample
cdr1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021573273A
Other languages
English (en)
Japanese (ja)
Other versions
JP7580406B2 (ja
JP2022536341A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037589 external-priority patent/WO2020252381A2/en
Publication of JP2022536341A publication Critical patent/JP2022536341A/ja
Publication of JP2022536341A5 publication Critical patent/JP2022536341A5/ja
Application granted granted Critical
Publication of JP7580406B2 publication Critical patent/JP7580406B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021573273A 2019-06-13 2020-06-12 抗ｔａｌｅｎ抗体およびその使用 Active JP7580406B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962861214P 2019-06-13 2019-06-13
US62/861,214 2019-06-13
PCT/US2020/037589 WO2020252381A2 (en) 2019-06-13 2020-06-12 Anti-talen antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2022536341A JP2022536341A (ja) 2022-08-15
JP2022536341A5 true JP2022536341A5 (enExample) 2023-06-20
JP7580406B2 JP7580406B2 (ja) 2024-11-11

Family

ID=73745889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573273A Active JP7580406B2 (ja) 2019-06-13 2020-06-12 抗ｔａｌｅｎ抗体およびその使用

Country Status (12)

Country Link
US (2) US11781248B2 (enExample)
EP (1) EP3983435A4 (enExample)
JP (1) JP7580406B2 (enExample)
KR (1) KR102993101B1 (enExample)
CN (1) CN113993891A (enExample)
AU (1) AU2020291939B2 (enExample)
BR (1) BR112021025029A2 (enExample)
CA (1) CA3138501A1 (enExample)
IL (1) IL288807B1 (enExample)
MX (1) MX2021015057A (enExample)
SG (1) SG11202112553WA (enExample)
WO (1) WO2020252381A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4008347B1 (en) * 2019-08-01 2025-04-30 Mie University GD2-BINDING MOLECULE

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US5869619A (en) 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US6242568B1 (en) 1994-01-18 2001-06-05 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
CA2196419C (en) 1994-08-20 2007-08-21 Yen Choo Improvements in or relating to binding proteins for recognition of dna
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
EP1913149A4 (en) 2005-07-26 2009-08-05 Sangamo Biosciences Inc TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
AU2008219972A1 (en) * 2007-02-27 2008-09-04 Forerunner Pharma Research Co., Ltd. Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient
KR101748707B1 (ko) 2009-11-27 2017-06-20 삼성전자주식회사 ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
US20110200595A1 (en) * 2010-02-18 2011-08-18 Roche Glycart TREATMENT WITH A HUMANIZED IgG CLASS ANTI EGFR ANTIBODY AND AN ANTIBODY AGAINST INSULIN LIKE GROWTH FACTOR 1 RECEPTOR
WO2013091903A1 (en) 2011-12-22 2013-06-27 Novo Nordisk A/S Anti-crac channel antibodies
US20150030602A1 (en) * 2011-12-23 2015-01-29 Phenoquest Ag Antibodies for the treatment and diagnosis of affective and anxiety disorders
AU2014255864B2 (en) * 2013-04-15 2019-07-18 Janssen Vaccines & Prevention B.V. Human antibodies binding to RSV G protein
US10011850B2 (en) 2013-06-21 2018-07-03 The General Hospital Corporation Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
CN111218447B (zh) 2013-11-07 2024-10-11 爱迪塔斯医药有限公司 使用统治型gRNA的CRISPR相关方法和组合物
EP3110454B1 (en) 2014-02-24 2020-11-18 Sangamo Therapeutics, Inc. Methods and compositions for nuclease-mediated targeted integration
EP3174897B1 (en) 2014-07-29 2020-02-12 F.Hoffmann-La Roche Ag Multispecific antibodies
FR3034420A1 (fr) * 2015-03-31 2016-10-07 Lab Francais Du Fractionnement Anticorps monoclonaux anti-cd303

Similar Documents

Publication Publication Date Title
JP2020023523A5 (enExample)
JP2020534830A5 (enExample)
IL273196B2 (en) Claudin6 antibodies and methods of treating cancer
JP2020537520A5 (enExample)
RU2010133547A (ru) Анти-cldn антитела
JP5941615B2 (ja) ヒトｃｘｃｌ１タンパク質の免疫学的測定方法
HRP20140049T1 (hr) Anti beta-amiloid antitijela i njihova upotreba
JP2021501744A5 (enExample)
NO20066052L (no) Anti-CD3 antistoffer og fremgangsmater for anvendelse derav
JP2020515277A5 (enExample)
JP2022528465A5 (enExample)
RU2015115399A (ru) Антигены, ассоциированные с воспалительным заболеванием кишечника
AU2024200122B2 (en) Apparatus and method for detecting microbial contamination
RU2442169C2 (ru) Система магнитного распознавания
JP2021501569A5 (enExample)
Yang et al. Single-domain antibodies as promising experimental tools in imaging and isolation of porcine epidemic diarrhea virus
JP2023507740A5 (enExample)
JP2023504620A5 (enExample)
CN119306837A (zh) 一种抗cd276的纳米抗体及其应用
AU595159B2 (en) Bispecific antibody determinants
HRP20192097T1 (hr) Protutijela protiv hpa-1a
Chen et al. Single Cell Microgels for High‐Throughput Magnetic Sorting and Sequencing of Antigen‐Specific Antibodies
Ferrara et al. Specific binder for Lightning-Link® biotinylated proteins from an antibody phage library
CN107102047A (zh) 一种检测鼠伤寒沙门氏菌的生物传感器
JP2023535684A5 (enExample)